Lung cancer target drug , lung cancer targeting drugs have several kinds of drug-target drug gene mutations
Clinical
| MRTX-849 | KRAS G12C |
| Taselisib | PIK3CA PIK3CD PIK3CG |
| AZD8186 | PIK3CB PIK3CD |
| AZD4547 | FGFR1、FGFR2、FGFR3 |
| Rociletinib | EGFR |
| Patritumab | EGFR |
| Naquotinib | EGFR |
| Onartuzumab | MET |
| PD173074 | FGFR1 VEGFR2 |
| MEDI4736 | PD-L1 |
| HLX10 | PD-1 |
| AZD-3759 | EGFR |
| GST-HG161 | c-Met |
| IBI305 | VEGF |
| WX-0593 | ALK/ROS1 |
| TQ-B3101 | ROS1 |
| M7824 | PD-1，TGF-β |
| CT-707 | ALK |
No comments:
Post a Comment